Project Grant R21HD118330

Award Date 7/1/25
Completion Date 6/30/27
Dollars Obligated $425K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $117,959 to the University of California, San Diego (UCSD) to conduct research on the impact of sex hormones and mechanical stretch on pelvic floor muscle structure and function during pregnancy and postpartum. The research involves two main components: 1) in vitro cell culture experiments to examine the...
This $734,639 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to determine the mechanisms of elastic fiber dynamics in the murine vagina, with a focus on the impact of age and injury. The project aims to: Identify the vaginal cell types that produce elastin during postpartum healing and whether production is constrained by age or injury. Elucidate the spatiotemporal dynamics of functional elastic fibers with and without...
This $1,459,877 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a bioinspired composite scaffold for repairing pubovisceral muscle enthesis (PVME) injuries in women following vaginal childbirth. The primary recipient, Magee-Womens Research Institute and Foundation, will utilize transperineal ultrasound, MRI shape modeling, and...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $497,016 to The Leland Stanford Junior University to conduct translational research on the mechanisms of oxytocin-mediated uterine contractility and uterine atony. The project aims to 1) determine the functional relationship between oxytocin and the TRPV4 calcium channel in normal uterine...
This federal Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to elucidate the role of hyaluronan matrices on the establishment and maintenance of ovarian reserve and reproductive longevity. The $232,308 award to the Magee-Womens Research Institute and Foundation in Pittsburgh, PA, will be used to test the hypothesis that the stromal...
This $2,495,639 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of a novel regenerative therapy to treat Genitourinary Syndrome of Menopause (GSM), a highly prevalent condition affecting up to 85% of perimenopausal and menopausal women. The project aims to create a tissue-specific extracellular matrix hydrogel that can reverse vaginal atrophy and restore healthy vaginal tissue function when delivered topically or via injection....
This federal Project Grant award, valued at $131,085 and issued by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to define the neural mechanisms that enable flexibility in innate social behaviors, with a focus on male mating in mice. The key objectives of the project are to: 1) delineate the afferent inputs onto preoptic hypothalamus neurons expressing tachykinin receptor 1,...
This $328,496 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development of a novel hydrogel film and applicator system to reduce pain experienced during sexual intercourse by women with vulvodynia and vestibulodynia. The goal is to create a non-pharmaceutical solution that can mitigate pain receptor activity and dissipate pressure on sensitive vulvar...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $643,049 to the University of Illinois to develop a physiomimetic model of the endometrioma lesion microenvironment. The objective is to investigate the processes responsible for the initiation and invasion of endometriosis lesions, which can lead to chronic pelvic pain and infertility. Specifically,...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $878,256 to Novagyn LLC to develop a natural, coaxial electrospun scaffold as an alternative to synthetic surgical mesh for the treatment of stress urinary incontinence (SUI) in women. The primary objectives are to fabricate coaxial scaffolds using silk fibroin and...

This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is providing $424,600.00 to The Leland Stanford Junior University to conduct research on the cellular mechanisms and microenvironment of the vagina in women with recurrent pelvic organ prolapse (POP) after previous POP surgery.

The research aims to 1) examine the effects of POP surgery on the human vagina through tissue biomechanical testing, histology, and gene/protein analysis, and 2) investigate altered vaginal fibroblast function in recurrent vaginal prolapse after POP surgery, including cellular gene/protein expression, secreted proteins, and fibroblast response to TGF-β1. This foundational research is intended to generate new insights into the vaginal landscape after failed POP surgery, which is critical for developing effective treatments to address high recurrence rates of vaginal prolapse. The project period is from July 1, 2025 to June 30, 2027.

Generated 6/24/25, 6:24 AM